AmpliGene India Biotech
PrivateLast Round
Accelerator
Jul 1, 2026
Total Funding Raised
$230,000
Company Overview
AmpliGene India Biotech is a biotechnology company that develops molecular diagnostic solutions, including isothermal amplification technology and point-of-care testing systems for clinical, veterinary, and agricultural applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AmpliGene India Biotech Comparables
Compare AmpliGene India Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OptiGene Limited | 85% | |
| Achira Labs Private Limited | 80% | |
| Huwel Lifesciences | 80% | |
AmpliGene India Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 1, 2026 |
AmpliGene India Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centre for Cellular and Molecular Platforms | Accelerator |
AmpliGene India Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AmpliGene India Biotech's valuation, stock price, and market status.